The Cigna Group — Earnings Quality Grade F
CI · Healthcare
Major red flags
Screening Summary
Management Signals
Source: SEC EDGAR 8-K Item 5.02, with exhibit links when available
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 43 days, change -2 days YoY
AR growth 7.4% vs revenue growth 12.5%
Revenue grew 12.5% but CFFO declined -7.4%
Expense Quality
No material inventory
CapEx growth -13.8% vs revenue 12.5%. Normal
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 1.61. Profits backed by cash
FCF $8.4B, FCF/NI = 1.41
Accruals ratio = -2.3%. Low accruals
Cash $8.6B covers only 27% of debt $31.5B
Balance Sheet Health
Goodwill+Intangibles $73.5B = 176% of equity. Over 50%
Insufficient data
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -0% YoY. Normal
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor CI continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25
